Brief: Marksans Pharma Acquires Capacity From Tevapharm India

Marksans Pharma

11/10/2022 10:54

Oct 11 (Reuters) - Marksans Pharma Ltd  MARK.NS :
    * ACQUIRES CAPACITY FROM TEVAPHARM INDIA
    * PLANS TO DOUBLE ITS MANUFACTURING FOOTPRINT
    * TRANSACTION IS IN CASH CONSIDERATION AND IS EXPECTED TO BE
FINALIZED BY APRIL 1, 2023
    * CO PLANS TO DOUBLE EXISTING INDIAN CAPACITY FROM 8 BILLION
UNITS
PER ANNUM CURRENTLY

Source text for Eikon:  ID:nBSE6G785 
Further company coverage:  MARK.NS 
 ((Reutersbriefs@thomsonreuters.com;))